{"id":"https://genegraph.clinicalgenome.org/r/53a6b92d-6574-444d-8ae7-5d41ad677da4v1.1","type":"EvidenceStrengthAssertion","dc:description":"PROK2 was first reported in relation to autosomal dominant Hypogonadotropic hypogonadism 4 with or without anosmia in 2006 (Dodé et al., PMID: 17054399). Hypogonadotropic hypogonadism is a disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. This can be caused by an isolated defect in gonadotropin-releasing hormone release, action, or both. Other associated nonreproductive phenotypes, such as anosmia, cleft palate, diabetes, sleep disorder, and sensorineural hearing loss, occur with variable frequency. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no differences in molecular mechanisms, inheritance patterns, and phenotypic variability. Therefore, the following disease entities have been lumped into one disease entity, hypogonadotropic hypogonadism 4 with or without anosmia (OMIM:610628), Kallman syndrome (KS), and  normosic congenital (idiopathic) hypogonadotropic hypogonadism (nIHH) in a semidominant inheritance pattern. Eighteen variants (missense, nonsense, frameshift, duplication, and insertion) that have been reported in 23 probands in 14 publications (PMIDs: 17054399, 17959774, 18559922, 18682503, 18985070, 23082007, 23596439, 24002956, 24031091, 25077900, 26141714, 30098700, 32870266, 33140874) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is known to be LOF. This gene-disease association is also supported by experimental evidence (animal models, expression studies, biochemical function, and protein interaction) (PMIDs: 12427552, 12604792, 15976302, 17093083, 17959774, 19784373, 24633064). One mouse model phenocopies hypogonadotropic hypogonadism and the expression study demonstrates PROK2 involvement in olfactory bulb neurogenesis. Another mouse model demonstrates that LOF in PROK2 can cause attenuated estrous cycles along with other circadian rhythms including sleep cycles and blood glucose regulation. PROK2 is expressed in the olfactory bulb and testis, proposed to modulate GnRH release as an SCN output molecule regulating circadian rhythms, and interacts with PROKR2 which is definitively associated with hypogonadotropic hypogonadism. In summary, PROK2 is definitively associated with semidominant Hypogonadotropic hypogonadism 4 with or without anosmia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This has been approved by the ClinGen Brain Malformations Gene Curation Expert Panel on 03/22/2022 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/53a6b92d-6574-444d-8ae7-5d41ad677da4","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660","calculatedEvidenceStrength":"Definitive","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2022-06-02T14:17:57.240Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10020","date":"2022-03-22T16:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60a04de2-3d9b-4c5b-bbd6-f6750c8a7c85_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/60a04de2-3d9b-4c5b-bbd6-f6750c8a7c85","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","rdfs:label":"Patient with KS (nonsense variant)","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7932dcf-e5ce-433a-94ea-3106ddf95403","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.364C>T (p.Arg122Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2491951"}},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/6c808035-c6b5-4711-80b8-1dc6bb16cbdc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7932dcf-e5ce-433a-94ea-3106ddf95403"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/6c808035-c6b5-4711-80b8-1dc6bb16cbdc","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6c808035-c6b5-4711-80b8-1dc6bb16cbdc_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/af7f693c-e15b-4129-b40b-d031cf21c00c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/af7f693c-e15b-4129-b40b-d031cf21c00c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","rdfs:label":"Patient with KS (1st missense variant)","allele":{"id":"https://genegraph.clinicalgenome.org/r/efc85928-1ae2-4a44-8c8d-5e9b8405db86","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.137G>A (p.Cys46Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353501131"}},"ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a6e01d24-1378-48e5-bbbf-b49ade61dc06_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","allele":{"id":"https://genegraph.clinicalgenome.org/r/efc85928-1ae2-4a44-8c8d-5e9b8405db86"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a6e01d24-1378-48e5-bbbf-b49ade61dc06","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a6e01d24-1378-48e5-bbbf-b49ade61dc06_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0d0bc0ce-365b-468f-a029-26eb4bc577a3_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0d0bc0ce-365b-468f-a029-26eb4bc577a3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30098700","rdfs:label":"No. 076","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5ea200f8-abf8-4a5a-8800-1c99e7ed5484","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.167G>C (p.Arg56Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353501067"}},"firstTestingMethod":"Next generation sequencing panels","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f5a4def9-9117-46d6-a2d2-a991b475847f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30098700","allele":{"id":"https://genegraph.clinicalgenome.org/r/5ea200f8-abf8-4a5a-8800-1c99e7ed5484"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f5a4def9-9117-46d6-a2d2-a991b475847f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f5a4def9-9117-46d6-a2d2-a991b475847f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9ed20478-21ad-40d0-864f-36d295b9d4cd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9ed20478-21ad-40d0-864f-36d295b9d4cd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077900","rdfs:label":"Individual with variant in PROK2","allele":{"id":"https://genegraph.clinicalgenome.org/r/efc85928-1ae2-4a44-8c8d-5e9b8405db86"},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e14a3ec6-04f1-47a5-aa64-b0bce89f8656_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25077900","allele":{"id":"https://genegraph.clinicalgenome.org/r/efc85928-1ae2-4a44-8c8d-5e9b8405db86"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/e14a3ec6-04f1-47a5-aa64-b0bce89f8656","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e14a3ec6-04f1-47a5-aa64-b0bce89f8656_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/879e3732-a064-4000-916a-53c6909a8f18_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/879e3732-a064-4000-916a-53c6909a8f18","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18682503","rdfs:label":"Case 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":23,"allele":{"id":"https://genegraph.clinicalgenome.org/r/d9324da4-03a8-4cd7-a49e-0daca05a247b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.297dup (p.Gly100fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2491964"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Decreased serum testosterone concentration, prepubertal basal and GnRH-stimulated gonadotropins","phenotypes":["obo:HP_0000771","obo:HP_0000054","obo:HP_0000458"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a753e8b6-1ff1-47a7-b31a-565fe11ec39b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18682503","allele":{"id":"https://genegraph.clinicalgenome.org/r/d9324da4-03a8-4cd7-a49e-0daca05a247b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a753e8b6-1ff1-47a7-b31a-565fe11ec39b","type":"EvidenceLine","dc:description":"Reduced scored from 1 point per variant due to homozygosity.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a753e8b6-1ff1-47a7-b31a-565fe11ec39b_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c5638449-6db1-434a-b30c-d15e9d8ee35e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c5638449-6db1-434a-b30c-d15e9d8ee35e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18985070","rdfs:label":"KS Patient with Variant in Exon 4","allele":{"id":"https://genegraph.clinicalgenome.org/r/80f125f6-12dc-4d4b-a30d-3bbe9b19275f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.310C>T (p.His104Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2491961"}},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec2c3604-bd95-46af-b6d1-72d926f999ed_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18985070","allele":{"id":"https://genegraph.clinicalgenome.org/r/80f125f6-12dc-4d4b-a30d-3bbe9b19275f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ec2c3604-bd95-46af-b6d1-72d926f999ed","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec2c3604-bd95-46af-b6d1-72d926f999ed_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1272276f-3fb4-4ebb-876f-11826dbbb282_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1272276f-3fb4-4ebb-876f-11826dbbb282","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","rdfs:label":"Patient with KS (2nd missense variant)","allele":{"id":"https://genegraph.clinicalgenome.org/r/2fd7be36-aaac-4001-a492-f6908ac5c090","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.301C>T (p.Arg101Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2491963"}},"firstTestingMethod":"PCR","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/64d51a9e-f50b-4b1d-a2c6-55e1c0496a75_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24031091","allele":{"id":"https://genegraph.clinicalgenome.org/r/2fd7be36-aaac-4001-a492-f6908ac5c090"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/64d51a9e-f50b-4b1d-a2c6-55e1c0496a75","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64d51a9e-f50b-4b1d-a2c6-55e1c0496a75_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/0cdd0512-bced-4941-8e9f-2c3a56878564_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0cdd0512-bced-4941-8e9f-2c3a56878564","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17959774","rdfs:label":"II-2","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a6aea08-07f0-4a89-a900-8c287e86355c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.163del (p.Ser54_Ile55insTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252841"}},"firstTestingMethod":"PCR","phenotypeFreeText":"cerebrovascular event (age 62) convulsive episode (age 29)\nunvirilized, prepubertal testes, hypogonadal testosterone, undetectable gonadotropins, hypoplastic olfactory sulci, apparent absent OB, normal kidney phenotypes as seen through imaging.","phenotypes":["obo:HP_0008187","obo:HP_0000458","obo:HP_0000044","obo:HP_0003003","obo:HP_0000819","obo:HP_0030260","obo:HP_0000771","obo:HP_0025502"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f3f4c58c-fc9e-4b94-93ad-6f992ef312cc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17959774","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a6aea08-07f0-4a89-a900-8c287e86355c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/f3f4c58c-fc9e-4b94-93ad-6f992ef312cc","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3f4c58c-fc9e-4b94-93ad-6f992ef312cc_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/f3f4c58c-fc9e-4b94-93ad-6f992ef312cc_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The 27-aa peptide was synthesized and tested to analyze its activity by using a CHO cell line that stably expresses the receptor PROKR2. Full-length human PROK2 potently activated PROKR2 at a low concentration (EC50 = 19 nM). However, the truncated PROK2 could not activate PROKR2 even at very high concentrations (>200 μM). Thus, the truncated form of PROK2 lacks functionality in vitro.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2ee74a66-60de-4fec-9552-9f6ceac8e338_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ee74a66-60de-4fec-9552-9f6ceac8e338","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","rdfs:label":"Subject no. 4","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.217C>T (p.Arg73Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252842"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000939","obo:HP_0000819","obo:HP_0008187"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/082af6bd-1b3b-4767-90e8-0275553903bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/082af6bd-1b3b-4767-90e8-0275553903bb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/082af6bd-1b3b-4767-90e8-0275553903bb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/082af6bd-1b3b-4767-90e8-0275553903bb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Functional analysis in CHO cells demonstrated a 7-fold decrease in calcium-mobilizing activity with the R73C mutant at the EC50 of wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5c3257a3-e03f-4e3e-aa4e-e43322fb0120_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c3257a3-e03f-4e3e-aa4e-e43322fb0120","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"Sporadic Case 1","allele":{"id":"https://genegraph.clinicalgenome.org/r/16432767-0b83-49c6-9949-8973f471e3b8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.-4C>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/801987"}},"firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/dd8fca3e-310e-4927-9094-38256dcae716_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","allele":{"id":"https://genegraph.clinicalgenome.org/r/16432767-0b83-49c6-9949-8973f471e3b8"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/dd8fca3e-310e-4927-9094-38256dcae716","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dd8fca3e-310e-4927-9094-38256dcae716_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/97d69f9e-2949-4408-9a0b-c9a9ccab8081_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/97d69f9e-2949-4408-9a0b-c9a9ccab8081","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26141714","rdfs:label":"Reference number 6","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25"},"firstTestingMethod":"PCR","phenotypeFreeText":"Basal LH: 0.1 IU/L, Basal FSH: 0.5 IU/L, Basal TT: 26 ng/dl, Basal mean testical size: 1 ml, Final mean testicular volume: 8 ml, Maximum sperm count: 8 million/ml","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/0bc82c72-d888-4c96-ac7e-dc41bf468058_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26141714","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:BiallelicHomozygous"}},"zygosity":{"id":"cg:BiallelicHomozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/0bc82c72-d888-4c96-ac7e-dc41bf468058","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bc82c72-d888-4c96-ac7e-dc41bf468058_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/aa0e7b9b-f16b-4568-a444-e2b3fb49e748_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa0e7b9b-f16b-4568-a444-e2b3fb49e748","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","rdfs:label":"Subject no. 3","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7f16996-eabe-4a98-a1e8-e39a31e9f10a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.101G>A (p.Cys34Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA270915"}},"firstTestingMethod":"PCR","phenotypeFreeText":"Sense of smell <5th %ile","phenotypes":"obo:HP_0008187","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/adda5b9d-a7bf-4ffb-8a82-c473ab3d7f5f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","allele":{"id":"https://genegraph.clinicalgenome.org/r/b7f16996-eabe-4a98-a1e8-e39a31e9f10a"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/adda5b9d-a7bf-4ffb-8a82-c473ab3d7f5f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/adda5b9d-a7bf-4ffb-8a82-c473ab3d7f5f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/adda5b9d-a7bf-4ffb-8a82-c473ab3d7f5f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"An aequorin-based luminescence assay was used to evaluate intracellular calcium mobilization. This variant completely eliminated the calcium mobilizing activity of PROK2 with a >1000-fold reduction at the Ec50 of the wild type.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3ee4a892-627c-4580-bcaf-10e50fa966f8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3ee4a892-627c-4580-bcaf-10e50fa966f8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","rdfs:label":"Subject no. 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/4514d072-771d-406b-afff-98b8857b2e2b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.150C>G (p.Ile50Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353501103"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0008187","obo:HP_0001335","obo:HP_0000458","obo:HP_0000028"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec0a2365-c20d-4ba7-a4da-94a1b5735fea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18559922","allele":{"id":"https://genegraph.clinicalgenome.org/r/4514d072-771d-406b-afff-98b8857b2e2b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/ec0a2365-c20d-4ba7-a4da-94a1b5735fea","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ec0a2365-c20d-4ba7-a4da-94a1b5735fea_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/513fd93e-2b44-4ba1-a64a-dcba5fd63766_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/513fd93e-2b44-4ba1-a64a-dcba5fd63766","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23082007","rdfs:label":"No. 20","ageType":"AgeAtReport","ageUnit":"Years","ageValue":22,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f0319aa0-9529-47c3-86a6-815581d2cfff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.137G>T (p.Cys46Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353501129"}},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0000458","obo:HP_0040327"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/94b6c901-6631-41e5-b3e9-e6dfa707d5ea_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23082007","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0319aa0-9529-47c3-86a6-815581d2cfff"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/94b6c901-6631-41e5-b3e9-e6dfa707d5ea","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94b6c901-6631-41e5-b3e9-e6dfa707d5ea_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1b1c597b-a763-47aa-9bc0-260472f15bc0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b1c597b-a763-47aa-9bc0-260472f15bc0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18985070","rdfs:label":"KS Patient with Variant in Exon 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/4ac27fb2-fc94-4fd5-8a99-1924a83280cd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.161G>A (p.Ser54Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA76545988"}},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a61886d6-1f20-4f24-8af8-9edd6e84c9a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18985070","allele":{"id":"https://genegraph.clinicalgenome.org/r/4ac27fb2-fc94-4fd5-8a99-1924a83280cd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/a61886d6-1f20-4f24-8af8-9edd6e84c9a2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a61886d6-1f20-4f24-8af8-9edd6e84c9a2_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8c6d283c-8fac-4b2d-bba0-6a28ec329181_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8c6d283c-8fac-4b2d-bba0-6a28ec329181","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23596439","rdfs:label":"Previously Unpublished","allele":{"id":"https://genegraph.clinicalgenome.org/r/beb6683c-8752-488f-833a-7ca4749fc32e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.302G>A (p.Arg101Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2491962"}},"sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/043a4139-c12b-49fe-b8fc-ed76148d015f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23596439","allele":{"id":"https://genegraph.clinicalgenome.org/r/beb6683c-8752-488f-833a-7ca4749fc32e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/043a4139-c12b-49fe-b8fc-ed76148d015f","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/043a4139-c12b-49fe-b8fc-ed76148d015f_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8d38bc7b-7e0b-4913-9b17-5cca29f922ec_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d38bc7b-7e0b-4913-9b17-5cca29f922ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18682503","rdfs:label":"Case 3","ageType":"AgeAtReport","ageUnit":"Years","ageValue":17,"allele":{"id":"https://genegraph.clinicalgenome.org/r/4a6aea08-07f0-4a89-a900-8c287e86355c"},"firstTestingMethod":"PCR","phenotypeFreeText":"Prepubertal testosterone and gonadotropin levels","phenotypes":"obo:HP_0030260","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/10347496-7313-4f4d-9ea1-dc7690048052_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18682503","allele":{"id":"https://genegraph.clinicalgenome.org/r/4a6aea08-07f0-4a89-a900-8c287e86355c"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/10347496-7313-4f4d-9ea1-dc7690048052","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/10347496-7313-4f4d-9ea1-dc7690048052_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e9c78940-8820-4443-bb16-7f0a61385322_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9c78940-8820-4443-bb16-7f0a61385322","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"II-4","allele":{"id":"https://genegraph.clinicalgenome.org/r/0861077d-4cb0-4225-b766-547a0a51d42b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.234_235insT (p.Asn79Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2499214027"}},"firstTestingMethod":"PCR","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/91d3fa35-7c8a-4aa2-a6c4-acb313d33595_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","allele":{"id":"https://genegraph.clinicalgenome.org/r/0861077d-4cb0-4225-b766-547a0a51d42b"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/91d3fa35-7c8a-4aa2-a6c4-acb313d33595","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/91d3fa35-7c8a-4aa2-a6c4-acb313d33595_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7cf02af3-b5e5-4fcd-92a9-d899e41a2900_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"Family F","family":{"id":"https://genegraph.clinicalgenome.org/r/7cf02af3-b5e5-4fcd-92a9-d899e41a2900","type":"Family","rdfs:label":"Family F","member":{"id":"https://genegraph.clinicalgenome.org/r/f87daed0-15d8-4656-8f87-b3c88cbc0e90","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"II-3","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2d3922-2592-42d4-a2a9-67bdb07cdd17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.94G>C (p.Gly32Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA252840"}},"firstTestingMethod":"PCR","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c30bd198-dab2-4659-a145-a580c8358dcb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b2d3922-2592-42d4-a2a9-67bdb07cdd17"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/f87daed0-15d8-4656-8f87-b3c88cbc0e90"}},{"id":"https://genegraph.clinicalgenome.org/r/5e4397b9-43e3-4a46-95c2-8aa9b47226a5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"Family E","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/5e4397b9-43e3-4a46-95c2-8aa9b47226a5","type":"Family","rdfs:label":"Family E","member":{"id":"https://genegraph.clinicalgenome.org/r/e9c78940-8820-4443-bb16-7f0a61385322"},"cg:modeOfInheritance":"Autosomal dominant/X-linked"},"meetsInclusionCriteria":false,"phenotypePositiveAllelePositive":4,"proband":{"id":"https://genegraph.clinicalgenome.org/r/e9c78940-8820-4443-bb16-7f0a61385322"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/cb951a58-4799-4905-a24d-475e070e5cc6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb951a58-4799-4905-a24d-475e070e5cc6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32870266","rdfs:label":"Individual with variant in PROK2","allele":{"id":"https://genegraph.clinicalgenome.org/r/69821c07-95e5-46c5-ac4e-b54fbcb40284","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001126128.2(PROK2):c.181A>G (p.Met61Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA353501034"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Hypothalamic amenorrhoea","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/8458ee09-2690-42de-b578-ac079d9b7132_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32870266","allele":{"id":"https://genegraph.clinicalgenome.org/r/69821c07-95e5-46c5-ac4e-b54fbcb40284"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/8458ee09-2690-42de-b578-ac079d9b7132","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8458ee09-2690-42de-b578-ac079d9b7132_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/f87daed0-15d8-4656-8f87-b3c88cbc0e90_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f87daed0-15d8-4656-8f87-b3c88cbc0e90"},{"id":"https://genegraph.clinicalgenome.org/r/c30bd198-dab2-4659-a145-a580c8358dcb","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c30bd198-dab2-4659-a145-a580c8358dcb_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/00df937a-89d4-4779-9945-68380a6b836a_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/00df937a-89d4-4779-9945-68380a6b836a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","rdfs:label":"Sporadic Case 2","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25"},"firstTestingMethod":"PCR","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/47e4855a-791e-4221-9d00-d333429e781e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17054399","allele":{"id":"https://genegraph.clinicalgenome.org/r/052b116d-22e3-4199-9b7f-e52a37ebbd25"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},"zygosity":{"id":"cg:MonoallelicHeterozygous"}},{"id":"https://genegraph.clinicalgenome.org/r/47e4855a-791e-4221-9d00-d333429e781e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/47e4855a-791e-4221-9d00-d333429e781e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/47e4855a-791e-4221-9d00-d333429e781e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Signaling properties in an aequorin-based luminescence assay to evaluate intracellular calcium mobilization. The full-length human PROK2 activated PROKR2 at a low concentration (EC50 ∼50 nm). The R73C variant resulted in a 7-fold decreased activity at the EC50 of wild type PMID:18559922","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b9299928-bb75-4b28-9165-c0eec606b4c5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e9a3083d-7ec2-463b-a03c-fdd38c1ded88","type":"Finding","dc:description":"PROK2 expression appeared restricted to testis and peripheral blood leukocytes. Northern blot analysis of human and mouse tissues verified these findings. These findings indicate that the testis is the major site of PROK2 expression in both human and rodents.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12604792","rdfs:label":"Dot-blot analysis on RNA arrays","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e42757e6-09cb-4d6d-8705-e0fdd63d0035","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/471565b4-7dc2-4f88-a10b-0675b6c3fbd5","type":"Finding","dc:description":"PROK2 was shown in the GL and PL of adult OB in a darkfield image and a cresyl violet staining.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15976302","rdfs:label":"Staining of PROK2 in the OB","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0c299e3f-7998-4ea9-9333-841769ff2c44","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b96ad88-4782-4875-952e-618df275cc2f","type":"Finding","dc:description":"PROKR2 is the receptor for PROK2, also implicated in hypogonadotropic hypogonadism.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12427552","rdfs:label":"Luciferase reporter gene assay","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a75b20bd-506e-489d-8a5c-41652b47d99c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2133c0db-2401-4308-a0dc-dcd35a2b0329","type":"Finding","dc:description":"LOF in PROK2 would lead to failure to modulate GnRH function, causing hypogonadotropic hypogonadism.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19784373","rdfs:label":"EGFP-immunostained fibers in suprachiasmatic nucleus","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2305ec95-325d-4ebe-9401-121705e49660_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/21296659-d4ec-46e7-8496-2952c015d94d","type":"EvidenceLine","dc:description":"This study used the same mouse model as the Ng KL et al. 2005, PMID: 15976302 publication. This piece of evidence is scored at 1 point for accounting for greater detail of the same mouse model with additional characteristic phenotypes of hypogonadotropic hypogonadism 4 with or without anosmia.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cbf92ef2-7de1-4afd-888d-7fa3e0dae6e7","type":"Finding","dc:description":"This phenotype, hypogonadotropic hypogonadism, is seen in human patients with pathogenic variants in PROK2.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17959774","rdfs:label":"Anatomical examination of PROK2 -/- mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/855169f6-fef4-4cd1-9789-6c9dc3d4c06b","type":"EvidenceLine","dc:description":"This study used the same mouse model as the Pitteloud et al. 2007, PMID: 17959774 publication. This piece of evidence is scored at 1 point for accounting for 1/2 of the same mouse model with characteristic phenotypes of the disease.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1aaff22e-d876-412b-bb75-964783302056","type":"Finding","dc:description":"OB of knockout mice were less than half the size of WT controls with ~50% displaying asymmetric bulb formation as well. Additionally, the granular cell layer was abnormally thin and the number of granular cells were reduced. The periglomerular layer was indiscernible/malformed in knockout mice. The smaller OB of knockout mice had significant enlargement of both the olfactory ventricle (OV) and the rostral migratory stream (RMS) at the entrance of the OB.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15976302","rdfs:label":"Nissl staining of OB in PROK2 KO Mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/db0f595c-83e0-4f7e-9c8d-0495a48f6df4","type":"EvidenceLine","dc:description":"This is the same mouse model used in Li et al. 2006. PMID:17093083. Therefore, this evidence is scored for 1 point as this mouse model detailed by Li et al. is scored for 1 point as well, for a total of 2 points.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0bca17c5-26a3-4ff4-b312-f8173aa63165","type":"Finding","dc:description":"This mouse model supports that PROK2 variation interrupts the pre-ovulatory GnRH surge, partially controlled by circadian outputs from the SCN to GnRH neurons.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24633064","rdfs:label":"Loss of one copy of PROK2 disrupts estrous cycles","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/c6e51049-24cf-49ca-b424-dcf5ed0e45ae","type":"EvidenceLine","dc:description":"This is the same mouse model used by Xiao L et al. 2014, PMID: 24633064. Therefore, this evidence was scored for 1 point as the Xiao L et al. publication is scored for another 1 point, for 2 points total.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4448df43-e9ea-4251-a72c-7705522deeb5","type":"Finding","dc:description":"Obesity, severe sleep disorder, and type 2 diabetes were seen in patients with hypogonadotropic hypogonadism which is likely attributed to the circadian role of PROK2.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17093083","rdfs:label":"Attenuated amplitudes of circadian oscillation.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":4541,"specifiedBy":"GeneValidityCriteria8","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/hDW9fIDr5J0","type":"GeneValidityProposition","disease":"obo:MONDO_0012528","gene":"hgnc:18455","modeOfInheritance":"obo:HP_0032113"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2305ec95-325d-4ebe-9401-121705e49660-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}